Belle Mead, NJ, United States of America

Nagaraju Poola

This inventor holds 1 USPTO granted patent. Top assignee: Amalive Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nagaraju Poola. Retrieved from https://idiyas.com/inventor/nagaraju-poola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nagaraju Poola: Inventor in Liver-Disease Treatment

Introduction

Nagaraju Poola is an inventor associated with Belle Mead, New Jersey, and Amalive Limited. His patent work concerns ornithine phenylacetate and its potential use in treating hyperammonemia.

Latest Patents

Poola is associated with 1 patent: “Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia.” The patent describes doses and methods of administering ornithine phenylacetate to treat or ameliorate hyperammonemia in patients with chronic liver disease, such as cirrhosis. Some embodiments address patients who also have hepatic encephalopathy.

Career Highlights

Poola’s listed patent reflects work on therapeutic approaches for managing hyperammonemia associated with chronic liver disease. He is associated with Amalive Limited.

Collaborations

The provided information lists Xiaofeng Wang Rears and Jack Tseng as Poola’s coworkers. It does not specify their roles or describe particular joint patent contributions.

Conclusion

Nagaraju Poola’s patent activity centers on ornithine phenylacetate dosing and administration for hyperammonemia, including in patients with chronic liver disease.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…